Researchers have pinpointed a critical process in the growth of Huntington’s disease, a currently incurable and ultimately fatal inherited neurological disorder affecting an estimated 3 to 7 per 100,000 people worldwide. A team at Ruhr-Universität Bochum has identified how the body attempts to clear the damaging proteins at the heart of the disease, and why that process fails, possibly opening avenues for future treatments. Their findings,published January 8,2026,in *Proceedings of the National Academy of Sciences*,focus on a cellular mechanism called ubiquitination and its impact on the mutated Huntingtin protein[[1]].
Ruhr-Universität Bochum
on February 5, 2026
Currently, there is no cure for Huntington’s disease, a devastating genetic disorder. The condition arises from a genetic mutation that causes the buildup of faulty proteins, leading to the disease’s characteristic symptoms. Researchers at the Department of Human Genetics at Ruhr-Universität Bochum have identified a key role for targeted ubiquitination – a process of marking proteins for destruction – at two specific locations on the mutated Huntingtin protein, impacting its breakdown and distribution within cells. These findings, published January 8, 2026, in Proceedings of the National Academy of Sciences, could offer a potential avenue for future therapeutic interventions.
Faulty Proteins Need Removal
Huntington’s disease is a rare, inherited condition that progressively damages nerve cells in the brain. The disease is caused by a mutation in the Huntingtin gene, resulting in a modified form of the Huntingtin protein. “This altered protein contains extended glutamine chains, causing it to misfold and lose its normal function,” explained Huu Phuc Nguyen. Misfolded proteins pose a threat to the body and need to be broken down. However, the mutated Huntingtin protein isn’t efficiently cleared and instead accumulates, eventually leading to symptoms like movement disorders, dementia, and psychiatric issues. “Currently, there is no cure for Huntington’s disease, and all those affected eventually succumb to it,” said Huu Phuc Nguyen. This underscores the urgent need for effective treatments for this debilitating condition.
Working with his team and international collaborators, including Nobel laureate Professor Aaron Ciechanover, who received the 2004 Nobel Prize in Chemistry for his work on protein degradation, the human geneticist is investigating the fundamental mechanisms of the disease. The current study focused on the breakdown of the proteins involved. “Before a damaged or misfolded protein can be degraded, it must first be marked and transported to the degradation complex within the cell,” Nguyen explained. “In the case of the Huntingtin protein, ubiquitination – marking with ubiquitin – at two specific sites, positions K6 and K9, plays a crucial role in its breakdown and distribution within the cell.” Once marked, these proteins are transported to the proteasome, the cell’s central protein degradation system, where they are eliminated.
Blocking the Marking Site Worsens the Disease
Researchers previously observed this process in cell cultures. In this latest work, the team replaced the mouse Huntingtin gene in a specialized “knock-in” mouse model with a human, disease-causing variant. A second mouse line was then created with alterations at the K6 and K9 binding sites of the Huntingtin protein, preventing ubiquitination. “We observed that this significantly worsened the symptoms of Huntington’s disease,” reported Huu Phuc Nguyen. “Signs of the disease also appeared earlier in mice that lacked the ability to mark the protein for degradation compared to mice with only the Huntingtin mutation.”
The researchers believe this discovery could provide a starting point for developing therapies against the disease. “Understanding the key sites for marking could enable us to stimulate the degradation process for damaged Huntingtin protein,” Nguyen said. “We suspect that the mutated protein escapes the degradation process because the structural changes caused by the disease and disrupted ubiquitination at critical positions impair its breakdown.” These findings offer a promising new direction for research into potential treatments for Huntington’s disease.
